Publications by authors named "Jaume Pons"

Claim this Profile
R
Revisiting the genetic epidemiology of ATTRv in Spain: the Balearic Islands as a high-prevalence founder focus.
Marc Ventayol-Guirado, Eugenia Cisneros-Barroso, Maria Antonia Ribot-Sansó, Juan González-Moreno, Inés Losada, Jaume Pons

Amyloid· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evorpacept plus rituximab for the treatment of relapsed or refractory non-Hodgkin lymphoma: results from the phase I ASPEN-01 study.
Tae Min Kim, Nehal J Lakhani, Jacob Soumerai, Manali Kamdar, Justin F Gainor, Jaume Pons

Haematologica· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic testing and evidence of a founder mutation in a hotspot for hereditary transthyretin amyloidosis.
Marc Ventayol-Guirado, Eugenia Cisneros-Barroso, Maria Antonia Ribot-Sanso, Juan Gonzalez-Moreno, Ines Losada, Jaume Pons

Sci Rep· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epitope Mapping Using Yeast Display and Next Generation Sequencing.
Thomas Van Blarcom, Andrea Rossi, Davide Foletti, Purnima Sundar, Steven Pitts, Jaume Pons

Methods Mol Biol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiopulmonary Complications after Pulmonary Embolism in COVID-19.
Carla Suarez-Castillejo, Néstor Calvo, Luminita Preda, Rocío Córdova Díaz, Nuria Toledo-Pons, Jaume Pons

Int J Mol Sci· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Gene as a Novel Cause of Thoracic Aortic Aneurysm in Patients with Tricuspid Aortic Valve: Two Cases Reported.
Laura Torres-Juan, Yolanda Rico, Elena Fortuny, Jaume Pons, Rafael Ramos

Int J Mol Sci· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication.
Johanna Theruvath, Marie Menard, Benjamin A H Smith, Miles H Linde, Garry L Coles, Jaume Pons

Nat Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01): a first-in-human, open-label, multicentre, phase 1 dose-escalation and dose-expansion study.
Nehal J Lakhani, Laura Q M Chow, Justin F Gainor, Patricia LoRusso, Keun-Wook Lee, Jaume Pons

Lancet Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Familial Dilated Cardiomyopathy and Sudden Cardiac Arrest: New Association with a Mutation.
Yolanda Rico, Maria Francisca Ramis, Montse Massot, Laura Torres-Juan, Jaume Pons

Genes (Basel)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the ESC quality indicators in patients with acute myocardial infarction: a systematic review.
Xavier Rossello, Albert Massó-van Roessel, Antoni Perelló-Bordoy, Caterina Mas-Lladó, Maria F Ramis-Barceló, Jaume Pons

Eur Heart J Acute Cardiovasc Care· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting mortality for patients with heart failure beyond oxygen consumption: a prognostic risk score.
Hanaa Shafiek, Andres Grau, Jaume Pons, Pere Pericas, Xavier Rossello

J Appl Physiol (1985)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct control of CAR T cells through small molecule-regulated antibodies.
Spencer Park, Edward Pascua, Kevin C Lindquist, Christopher Kimberlin, Xiaodi Deng, Jaume Pons

Nat Commun· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity.
Tracy C Kuo, Amy Chen, Ons Harrabi, Jonathan T Sockolosky, Anli Zhang, Jaume Pons

J Hematol Oncol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of pulmonary embolism in patients with COVID-19 pneumonia and high D-dimer values: A prospective study.
Alberto Alonso-Fernández, Nuria Toledo-Pons, Borja G Cosío, Aina Millán, Néstor Calvo, Jaume Pons

PLoS One· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of high affinity, pan-allelic, and pan-mammalian reactive antibodies against the myeloid checkpoint receptor SIRPα.
Janet Sim, Jonathan T Sockolosky, Emma Sangalang, Shelley Izquierdo, Darlene Pedersen, Jaume Pons

MAbs· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunoescape the link between emphysema and lung cancer?
Jaume Sauleda, Francisco Javier Verdú, Sergio Scrimini, Ernest Sala, Jaume Pons

J Thorac Dis· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALX148 blocks CD47 and enhances innate and adaptive antitumor immunity with a favorable safety profile.
Steven E Kauder, Tracy C Kuo, Ons Harrabi, Amy Chen, Emma Sangalang, Jaume Pons

PLoS One· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Productive common light chain libraries yield diverse panels of high affinity bispecific antibodies.
Thomas Van Blarcom, Kevin Lindquist, Zea Melton, Wai Ling Cheung, Chris Wagstrom, Jaume Pons

MAbs· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epitope Mapping Using Yeast Display and Next Generation Sequencing.
Thomas Van Blarcom, Andrea Rossi, Davide Foletti, Purnima Sundar, Steven Pitts, Jaume Pons

Methods Mol Biol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of single- and multiple-dose administration of bococizumab (RN316/PF-04950615), a humanized IgG2Δa monoclonal antibody binding proprotein convertase subtilisin/kexin type 9, in hypercholesterolemic subjects treated with and without atorvastatin: Results from four phase I studies.
Barry Gumbiner, Tenshang Joh, Hong Liang, Hong Wan, Matteo Levisetti, Jaume Pons

Cardiovasc Ther· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved Lysosomal Trafficking Can Modulate the Potency of Antibody Drug Conjugates.
Rachel M DeVay, Kathy Delaria, Guoyun Zhu, Charles Holz, Davide Foletti, Jaume Pons

Bioconjug Chem· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Follicular T Cells from smB Common Variable Immunodeficiency Patients Are Skewed Toward a Th1 Phenotype.
Vanesa Cunill, Antonio Clemente, Nallibe Lanio, Carla Barceló, Valero Andreu, Jaume Pons

Front Immunol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RN927C, a Site-Specific Trop-2 Antibody-Drug Conjugate (ADC) with Enhanced Stability, Is Highly Efficacious in Preclinical Solid Tumor Models.
Pavel Strop, Thomas-Toan Tran, Magdalena Dorywalska, Kathy Delaria, Russell Dushin, Jaume Pons

Mol Cancer Ther· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline-encoded neutralization of a Staphylococcus aureus virulence factor by the human antibody repertoire.
Yik Andy Yeung, Davide Foletti, Xiaodi Deng, Yasmina Abdiche, Pavel Strop, Jaume Pons

Nat Commun· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineering Highly Potent and Selective Microproteins against Nav1.7 Sodium Channel for Treatment of Pain.
Anatoly Shcherbatko, Andrea Rossi, Davide Foletti, Guoyun Zhu, Oren Bogin, Jaume Pons

J Biol Chem· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis